|
|
| BC | supplementation |
| placebo |
|
|
|
|
| Baseline | 4 months | d | Baseline | 4 months | d |
| BMD_LS (g/cm2) | Normal | 1.2 ± 0.2 | 1.2 ± 0.1 | 0.03 | 1.1 ± 0.1 | 1.1 ± 0.1 | 0.14 |
| Osteopenia | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.10 | 1.0 ± 0.1 | 0.8 ± 0.8 | 0.36 | |
| Osteporosis | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.17 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.01 | |
| BMD_FN (g/cm2) | Normal | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.05 | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.02 |
| Osteopenia | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.25 | 0.9 ± 0.1 | 0.8 ± 0.4a | 0.42 | |
| Osteporosis | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.11 | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.11 | |
| BMD_Arm (g/cm2) | Normal | 0.1 ± 0.06 | 0.6 ± 0.7 | 0.82 | 0.8 ± 0.1 | 0.6 ± 0.6 | 0.48 |
| Osteopenia | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.17 | 0.9 ± 0.1 | 0.7 ± 0.6 | 0.45 | |
| Osteporosis | 0.7 ± 0.2 | 0.8 ± 0.1 | 0.16 | 0.6 ± 0.1 | 0.7 ± 0.1 | 0.68 |